The biggest problems in modern healthcare are not medical failures – they are systems failures. And systems failures require founders willing to build new tools, new models, and new infrastructure. Here is the case for entrepreneurship at the centre of healthcare’s future.
The clinicians I have spent time with in the course of building Qlupod AG are, almost without exception, brilliant at the specific work of medicine: diagnosing, treating, managing, communicating. They are frequently frustrated by everything around that work. The records system that does not communicate with the system used by the specialist across town. The referral process that takes four weeks for
something clinically urgent. The monitoring data on a patient’s phone that has no pathway into the clinical record. The appointment that lasts ten minutes for a patient with fifteen years of chronic disease history. These are not failures of clinical knowledge. They are failures of systems. And systems failures are, fundamentally, an entrepreneurial problem.
This is the case for why healthcare needs more founders – not instead of doctors, not in competition with clinical expertise, but alongside it. Building the tools, the platforms, the devices, and the models of care that allow clinical excellence to operate at the scale and the consistency that modern populations require.
The Gap That Medicine Cannot Fill Alone
Modern medicine has extraordinary capabilities. The diagnostic tools available to clinicians today – imaging, genomics, biomarkers – would have seemed miraculous to a physician of fifty years ago. The therapeutic options for conditions that were previously untreatable or fatal continue to expand. Life expectancy in high-income countries has risen dramatically over the past century, driven substantially by medical advances.
What medicine is structurally less equipped to do is to consistently apply those capabilities at scale, across dispersed populations, through health systems that are simultaneously serving growing numbers of patients with growing complexity of conditions, with workforces that are not expanding fast enough to meet demand through conventional means. The gap is not in clinical knowledge – it is in the infrastructure that connects clinical knowledge to patients who need it.
Remote patient monitoring, telemedicine, digital therapeutics, predictive analytics, home diagnostics – these are the categories of technology that can help close that gap. Not by replacing clinical judgment, but by extending its reach: allowing a clinician’s expertise to benefit a patient they are not physically present with, to act on data they would not otherwise have access to, and to intervene earlier than a clinic appointment schedule would permit.
What the Best Health Tech Founders Know
The health technology founders who build companies that last are the ones who approach the sector’s complexity as a feature rather than a problem to work around. They understand that regulatory requirements exist because medical devices affect human health, and that meeting those requirements is the foundation of clinical trust rather than a barrier to it. They build with clinicians rather than around them, understanding that a product which is not endorsed by the clinical community it serves will not reach the patients who need it, regardless of its technical merits. They invest in clinical validation
before commercial pressure makes them want to shortcut it – because the validation data is the most durable competitive asset they will build.
They also understand the specific dynamics of healthcare markets: that buying decisions are made at the intersection of clinical evidence, health system incentives, and regulatory frameworks; that reimbursement pathways are as important as product features; and that the pace of change in clinical practice is slower, and more deliberate, than in consumer technology – for good reasons that deserve respect rather than impatience.
The Regulatory Landscape: A Feature, Not a Bug
European medical device regulation – specifically the EU Medical Device Regulation (MDR) that came into full effect in recent years – is among the most demanding regulatory frameworks for medical devices anywhere in the world. It requires comprehensive clinical evidence, rigorous quality management systems, post-market surveillance, and ongoing compliance with updated standards. For a startup building a certified medical device, this represents a significant investment of time, resource, and expertise.
It is also, from the perspective of clinical trust, an asset. A device that has navigated full MDR compliance carries a credibility signal that no amount of marketing can replicate. Clinicians who recommend devices to patients are staking their professional credibility on those recommendations. A regulatory framework that ensures the devices they recommend are genuinely accurate, safe, and fit for clinical purpose is the foundation of the clinical relationship that health tech companies need to build. QluPod’s certification is not a certificate on a wall – it is the proof of accuracy that makes clinical recommendation possible.
Why Southeast Europe Is an Emerging Hub for Health Tech
The conventional narrative of European health technology locates its centre of gravity in Western Europe – Switzerland, Germany, the Netherlands, Sweden – where established medtech industries, well-funded health systems, and sophisticated regulatory environments provide both the market and the infrastructure for health tech development. This narrative is accurate as far as it goes, but it misses a rapidly developing part of the picture.
Southeast Europe – the Balkans and adjacent countries – is emerging as a significant contributor to European health technology, driven by a combination of strong technical talent, growing investor interest, and healthcare systems that provide unusually clear visibility into the problems that digital health can solve. Rural populations with limited specialist access. Aging demographics with high chronic disease burden. Healthcare workforces under pressure from both demand growth and emigration to higher-wage Western systems. These conditions create both the urgency and the market that health tech founders need to build against.
Programmes like The Founder Games – which explicitly cultivates health technology and other deep tech founders within the Southeast European ecosystem – are part of the infrastructure that will make this emergence durable rather than episodic. The founders connecting through these programmes, the investors building regional portfolios, and the companies like Qlupod AG that bridge Swiss regulatory credibility with Balkan market understanding, are together creating the conditions for a regional health tech ecosystem that did not exist a decade ago.
The Obligation of Opportunity
There is, for founders working in health technology, a dimension to the work that is not present in most other sectors: the knowledge that the problem being addressed is one of genuine human consequence. A person whose atrial fibrillation goes undetected because they never had access to home ECG monitoring, and who subsequently has a preventable stroke, is a person whose life has been materially affected by the gap that a health tech company failed to fill. This is a weighty thing to carry. It is also, for the right founders, the source of the conviction that sustains the work through its most difficult
periods.
Healthcare needs more founders precisely because the stakes are high enough to make the work meaningful, and the problems are large enough to absorb the efforts of many talented people across many years. The opportunity and the obligation coincide. For founders with the right combination of clinical understanding, technical capability, and the sustained conviction to keep building when the path is uncertain – this is one of the most important places to be.
Conclusion
The future of healthcare will be built by a combination of clinical expertise and entrepreneurial energy working in genuine partnership. Neither is sufficient alone. The clinician without the tools to monitor patients between appointments cannot deliver the proactive care that chronic disease management requires. The founder without clinical understanding cannot build the tools that earn clinical trust. The most important companies in health technology are the ones that have found the intersection – and built there, with patience, rigour, and the conviction that the problem is worth solving no matter how long it takes.
English 
German 
French 
Italian 
Spanish 
Albanian 
Serbian 
Macedonian 
Greek